These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 1566297)

  • 1. Electrocardiographic alterations during treatment of mucocutaneous leishmaniasis with meglumine antimoniate and allopurinol.
    Antezana G; Zeballos R; Mendoza C; Lyevre P; Valda L; Cardenas F; Noriega I; Ugarte H; Dedet JP
    Trans R Soc Trop Med Hyg; 1992; 86(1):31-3. PubMed ID: 1566297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined antimonial allopurinol therapy in mucosal leishmaniasis.
    Sampaio RN; Marchán EM; Vexenat A; Tristão RJ; Marsden PD
    Mem Inst Oswaldo Cruz; 1990; 85(3):373-4. PubMed ID: 2134714
    [No Abstract]   [Full Text] [Related]  

  • 3. Low dosage combination of meglumine antimoniate plus allopurinol as first choice treatment of infantile visceral leishmaniasis in Italy.
    di Martino L; Mantovani MP; Gradoni L; Gramiccia M; Guandalini S
    Trans R Soc Trop Med Hyg; 1990; 84(4):534-5. PubMed ID: 2091347
    [No Abstract]   [Full Text] [Related]  

  • 4. Mucosal leishmaniasis unresponsive to glucantime therapy successfully treated with AmBisome.
    Nonata R; Sampaio R; Marsden PD
    Trans R Soc Trop Med Hyg; 1997; 91(1):77. PubMed ID: 9093636
    [No Abstract]   [Full Text] [Related]  

  • 5. [Miltefosine or meglumine antimoniate in leishmaniasis].
    Joob B; Wiwanitkit V
    Medicina (B Aires); 2015; 75(2):130-1. PubMed ID: 25919881
    [No Abstract]   [Full Text] [Related]  

  • 6. [Miltefosine versus meglumine antimoniate in the treatment of mucosal leishmaniasis].
    Garcia Bustos MF; Barrio A; Parodi C; Beckar J; Moreno S; Basombrio MA
    Medicina (B Aires); 2014; 74(5):371-7. PubMed ID: 25347898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retention of antimony in hair during leishmaniasis treatment.
    Dorea JG; Merchan-Hamann E; Ryan DE; Holzbecher J
    Clin Chim Acta; 1989 Feb; 179(3):341-5. PubMed ID: 2714007
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of antimonial therapy for canine leishmaniasis on antibody titer.
    Amusategui I; Sainz A; Tesouro MA
    Ann N Y Acad Sci; 1998 Jun; 849():444-6. PubMed ID: 9668509
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in an infant who developed pancreatitis caused by meglumine antimoniate.
    Kuyucu N; Kara C; Bakirtaç A; Teziç T
    Pediatr Infect Dis J; 2001 Apr; 20(4):455-7. PubMed ID: 11332679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of allopurinol plus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV.
    Laguna F; López-Vélez R; Soriano V; Montilla P; Alvar J; González-Lahoz JM
    J Infect; 1994 May; 28(3):255-9. PubMed ID: 8089514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The renal transplant patient with visceral leishmaniasis who could not tolerate meglumine antimoniate-cure with ketoconazole and allopurinol.
    Hueso M; Bover J; Serón D; Gil-Vernet S; Rufí G; Alsina J; Grinyó JM
    Nephrol Dial Transplant; 1999 Dec; 14(12):2941-3. PubMed ID: 10570102
    [No Abstract]   [Full Text] [Related]  

  • 12. Evolution of serum albumin/globulin ratio after antimonial therapy in canine leishmaniasis.
    Amusategui I; Sainz A; Tesouro MA
    Ann N Y Acad Sci; 1998 Jun; 849():447-9. PubMed ID: 9668510
    [No Abstract]   [Full Text] [Related]  

  • 13. [A case of mucocutaneous leishmaniasis treated with success with a low dose of pentavalent antimonial].
    Amato VS; de Oliveira LS; Silva AC; Machado FR; Amato JG; Nicodemo AC; Amato Neto V
    Rev Soc Bras Med Trop; 1998; 31(2):221-4. PubMed ID: 9608241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of cutaneous leishmaniasis with a combination of allopurinol and low-dose meglumine antimoniate.
    Momeni AZ; Reiszadae MR; Aminjavaheri M
    Int J Dermatol; 2002 Jul; 41(7):441-3. PubMed ID: 12121563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Renal function in patients with mucocutaneous leishmaniasis treated with pentavalent antimony compounds].
    Veiga JP; Rosa TT; Kimachi T; Wolff ER; Sampaio RN; Gagliardi AR; Junqueira Júnior LF; Costa JM; Marsden PD
    Rev Inst Med Trop Sao Paulo; 1985; 27(6):298-302. PubMed ID: 3014634
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of the mucosal form of leishmaniasis without response to glucantime, with liposomal amphotericin B].
    Sampaio RN; Marsden PD
    Rev Soc Bras Med Trop; 1997; 30(2):125-8. PubMed ID: 9148335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allopurinol in the treatment of American cutaneous leishmaniasis.
    Martinez S; Marr JJ
    N Engl J Med; 1992 Mar; 326(11):741-4. PubMed ID: 1738379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of cutaneous leishmaniasis recidivans with a combination of allopurinol and meglumine antimoniate: a clinical and histologic study.
    Esfandiarpour I; Dabiri SH
    Int J Dermatol; 2007 Aug; 46(8):848-52. PubMed ID: 17651170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of mucocutaneous leishmaniasis in littoral Bahia, Brazil.
    Lago L; Vieira JB; Costa JL; Marsden PD
    Trans R Soc Trop Med Hyg; 1990; 84(2):241. PubMed ID: 2389315
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of recurrent cutaneous Leishmaniasis.
    Momeni AZ; Aminjavaheri M
    Int J Dermatol; 1995 Feb; 34(2):129-33. PubMed ID: 7737774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.